Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2008-01-14

Clinical Trial Update: Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial investigating desmopressin and dexamethasone as adjunctive treatment for leptospirosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Desmopressin (Desmopressin)

Snippet

Sponsor: Mahidol University | Conditions: Leptospirosis | Phase 2, Phase 3 | Status: TERMINATED